Compare GPGI & PTGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GPGI | PTGX |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | United States | United States |
| Employees | 977 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.2B |
| IPO Year | N/A | 2016 |
| Metric | GPGI | PTGX |
|---|---|---|
| Price | $16.36 | $105.73 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $108.23 |
| AVG Volume (30 Days) | ★ 3.3M | 689.5K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.06% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $768.10 | $873.97 |
| Revenue Next Year | $126.25 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.48 | $41.29 |
| 52 Week High | $25.66 | $107.84 |
| Indicator | GPGI | PTGX |
|---|---|---|
| Relative Strength Index (RSI) | 40.87 | 59.17 |
| Support Level | $15.48 | $76.63 |
| Resistance Level | $18.83 | $107.84 |
| Average True Range (ATR) | 0.87 | 3.88 |
| MACD | 0.19 | -0.11 |
| Stochastic Oscillator | 41.27 | 83.00 |
GPGI Inc is a diversified holding permanent capital platform designed to acquire, own, and scale high-quality businesses that hold great positions in good industries.
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.